• Sustainability
  • DE&I
  • Pandemic
  • Finance
  • Legal
  • Technology
  • Regulatory
  • Global
  • Pricing
  • Strategy
  • R&D/Clinical Trials
  • Opinion
  • Executive Roundtable
  • Sales & Marketing
  • Executive Profiles
  • Leadership
  • Market Access
  • Patient Engagement
  • Supply Chain
  • Industry Trends

Pharma Pulse 1/16/25: 5 Predictions That Will Drive R&D Effectiveness in 2025, Key Drugs to Watch for Community Pharmacy & more

News
Article

The latest news for pharma industry insiders.

Five Predictions That Will Drive R&D Effectiveness in 2025

A focus on data and process excellence advances product development.

Key Drugs to Watch for Community Pharmacy in 2025

These drugs are set to revolutionize their respective disease states in 2025.

Why ‘Cost Avoidance’ Became an AI Buzzword for Holding Down Headcount

The term helps business technology leaders justify the high cost of artificial intelligence.

Happen Ventures Helps Honest Medical Divert Surplus Medical Supplies

Happen Ventures, a leader in beneficial reuse, has partnered with Honest Medical to address their excess inventory problem through their innovative Beneficial Reuse Program. This initiative enabled Honest Medical to donate surplus medical supplies to local nonprofits like Hope Esperanza.

UpScriptHealth on LinkedIn

In a recent interview with Pharmaceutical Executive, our founder & CEO Peter Ax, uncovered how #telehealth is evolving to meet complex healthcare needs. From streamlining prior authorizations to leveraging AI for enhanced patient care, UpScriptHealth is working to reduce administrative burdens and improve access to medications.

#DigitalHealth #Healthcare

Have news you want us to share in Pharma Pulse? Reach out to Editor Miranda Schmalfuhs